Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb 20;104(8):2827-30.
doi: 10.1073/pnas.0700021104. Epub 2007 Feb 16.

Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13

Affiliations

Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13

Antonios O Aliprantis et al. Proc Natl Acad Sci U S A. .

Abstract

Tissue remodeling with fibrosis is a predominant pathophysiological mechanism of many human diseases. Systemic sclerosis is a rare, often lethal, disorder of unknown etiology manifested by dermal fibrosis (scleroderma) and excessive connective tissue deposition in internal organs. Currently, there are no available antifibrotic therapeutics, a reflection of our lack of understanding of this process. Animal models of scleroderma are useful tools to dissect the transcription factors and cytokines that govern fibrosis. A disproportionate increase of type 2 cytokines, like TGF-beta and IL-4, more than type 1 cytokines, like IFN-gamma, is thought to underlie the pathogenesis of scleroderma. In this study, we show that mice deficient in the transcription factor T-box expressed in T cells (T-bet), a master regulator of type 1 immunity, display increased sensitivity to bleomycin-induced dermal sclerosis. Despite the well-established role of T-bet in adaptive immunity, we also show that RAG2(-/-) mice, which lack T and B cells, are vulnerable to bleomycin-induced scleroderma and that RAG2/T-bet double-deficient mice maintain the increased sensitivity to bleomycin observed in T-bet(-/-) mice. Furthermore, overexpression of T-bet in T cells does not affect the induction of skin sclerosis in this model. Lastly, we show that IL-13 is the profibrotic cytokine regulated by T-bet in this model. Together, we conclude that T-bet serves as a repressor of dermal sclerosis through an IL-13-dependent pathway in innate immune cells. T-bet, and its transcriptional network, represent an attractive target for the treatment of systemic sclerosis and other fibrosing disorders.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: L.H.G. has equity in and is on the corporate board of Bristol–Myers Squibb Company.

Figures

Fig. 1.
Fig. 1.
Bleomycin-induced skin sclerosis does not require the adaptive immune system. BALB/c (WT) or RAG2−/− mice on BALB/c background (RAG2 KO) received s.c. injections of PBS (□) or bleomycin (■) for 4 weeks to induce skin sclerosis. The degree of collagen deposition was measured by a hydroxyproline assay. Statistically significant increases were observed in the hydroxyproline content in the skin of bleomycin-treated WT and RAG2−/− mice compared with PBS-treated control mice (P = 0.020 and 0.019, respectively). No statistical difference was observed in the hydroxyproline content in the skin of bleomycin-treated WT or RAG2−/− mice (∗, P > 0.05).
Fig. 2.
Fig. 2.
Histopathological analysis of bleomycin-treated T-bet KO mice reveals increased dermal sclerosis compared with WT mice. Skin sections from BALB/c (WT) and T-bet−/− (Tbet KO) mice injected daily for 4 weeks with bleomycin or PBS were stained with H&E (A–D) or Masson trichrome (E–H). Note the increased skin thickness and more robust deposition of collagen observed in bleomycin-treated TbetKO mice compared with similarly treated WT mice.
Fig. 3.
Fig. 3.
The transcription factor T-bet functions within the innate immune system to augment bleomycin-induced skin sclerosis. (A) BALB/c (WT), T-bet−/− mice (Tbet KO), and RAG2−/− × T-bet−/− DKO mice (Tbet/RAG2 DKO) received s.c. injections of PBS (□) or bleomycin (■) for 4 weeks to induce skin sclerosis. The degree of collagen deposition was measured by a hydroxyproline assay (∗, P < 0.002; ∗∗, P < 0.05). The results are representative of four independent experiments. (B) BALB/c (WT) and transgenic mice that overexpress T-bet under the control of the CD2 promoter were treated with bleomycin and analyzed as in (A) (∗, P > 0.05). The data represent the average values of each group of mice (n = 3–6) with standard deviation. Asterisks denote statistical significance. The results are representative of two independent experiments.
Fig. 4.
Fig. 4.
T-bet regulate dermal sclerosis through IL-13. Seven- to 8-week-old BALB/c (WT), IL-13−/− mice on BALB/c background (IL-13 KO), and T-bet−/− × IL-13−/− mice (Tbet/IL-13 DKO) received s.c. bleomycin injections for 4 weeks to induce skin sclerosis. The degree of collagen deposition was measured by a hydroxyproline assay (∗, P < 0.05; ∗∗, P < 0.05). The data represent the average values of each group of mice (n = 3–5) with standard deviation. Asterisks denote statistical significance. The results shown are representative of three separate experiments.

References

    1. Wynn TA. Nat Rev Immunol. 2004;4:583–594. - PMC - PubMed
    1. Denton CP, Black CM, Abraham DJ. Nat Clin Pract Rheumatol. 2006;2:134–144. - PubMed
    1. McGaha TL, Le M, Kodera T, Stoica C, Zhu J, Paul WE, Bona CA. Arthritis Rheum. 2003;48:2275–2284. - PubMed
    1. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. J Rheumatol. 1997;24:328–332. - PubMed
    1. Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM. J Rheumatol. 1995;22:1876–1883. - PubMed

Publication types

LinkOut - more resources